In lung adenocarcinoma, significantly low expression of METTL3 inhibits m6A modification and translation of the E3 ubiquitin ligase FBXW7, resulting in reduced levels of ubiquitination and degradation of oncogenes such as MYC, accelerating tumor metastasis [99]. Here, METTL3 is linked to neoplasm.